Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan
- 1 January 2010
- journal article
- research article
- Published by Elsevier in Matrix Biology
- Vol. 29 (1), 63-73
- https://doi.org/10.1016/j.matbio.2009.09.005
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (P19074-B05, CA47282, RO1 CA39481)
- Australian Research Council (P19074-B05, CA47282, RO1 CA39481)
- Austrian Science Fund (P19074-B05, CA47282, RO1 CA39481)
- Austrian Science Fund (P19074-B05, CA47282, RO1 CA39481)
- National Institutes of Health (P19074-B05, CA47282, RO1 CA39481)
This publication has 52 references indexed in Scilit:
- Diverse Cell Signaling Events Modulated by PerlecanBiochemistry, 2008
- Degradation of extracellular matrix and its components by hypobromous acidBiochemical Journal, 2006
- Structural Requirements for Heparin/Heparan Sulfate Binding to Type V CollagenJournal of Biological Chemistry, 2006
- Tyrosine Modification Is Not Required for Myeloperoxidase-induced Loss of Apolipoprotein A-I Functional ActivitiesPublished by Elsevier ,2005
- Basement membrane proteoglycans: from cellar to ceilingNature Reviews Molecular Cell Biology, 2005
- Heparan Sulfate: A Complex Polymer Charged with Biological ActivityChemical Reviews, 2005
- Basement membrane assembly, stability and activities observed through a developmental lensMatrix Biology, 2004
- Endothelial and Fibroblast Cell-Derived Heparan Sulphate Bind with Differing Affinity to Basic Fibroblast Growth FactorBiochemical and Biophysical Research Communications, 1998
- Hypochlorous Acid Disrupts the Adhesive Properties of Subendothelial MatrixFree Radical Biology & Medicine, 1997
- Immunologic Detection and Measurement of Hypochlorite-Modified LDL With Specific Monoclonal AntibodiesArteriosclerosis, Thrombosis, and Vascular Biology, 1995